no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acute coronary syndrome in calcium pyrophosphate deposition disease patients: A US inpatient care cohort study
|
Parperis, Konstantinos |
|
|
67 |
C |
p. |
article |
2 |
Added value of the salivary gland ultrasonography OMERACT score in the ACR/EULAR classification criteria for Sjögren's disease
|
Rebel, Dagmar |
|
|
67 |
C |
p. |
article |
3 |
Advancing autoimmune Rheumatic disease treatment: CAR-T Cell Therapies - Evidence, Safety, and future directions
|
Ohno, Ryunosuke |
|
|
67 |
C |
p. |
article |
4 |
Adverse cardiovascular events in rheumatoid arthritis patients treated with JAK inhibitors: An analysis of postmarketing spontaneous safety reports
|
Goldman, Adam |
|
|
67 |
C |
p. |
article |
5 |
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis
|
Bandini, Giulia |
|
|
67 |
C |
p. |
article |
6 |
Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis
|
Uzun, Güllü Sandal |
|
|
67 |
C |
p. |
article |
7 |
Assessment of enthesopathy in conventional pelvis radiography: Another tool for spondyloarthritis diagnosis beyond sacroiliitis
|
Enrique, Calvo-Paramo |
|
|
67 |
C |
p. |
article |
8 |
Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort
|
Dyball, Sarah |
|
|
67 |
C |
p. |
article |
9 |
Commentary on giant cell arteritis associated with scalp, tongue or lip necrosis in a French study
|
Wang, Feng |
|
|
67 |
C |
p. |
article |
10 |
Comment to “Vitamin D in psoriatic arthritis - A systematic review and meta-analysis”
|
Formisano, Elena |
|
|
67 |
C |
p. |
article |
11 |
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
|
Lakin, Kimberly S. |
|
|
67 |
C |
p. |
article |
12 |
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence
|
Doumen, Michaël |
|
|
67 |
C |
p. |
article |
13 |
Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: A systematic review and meta-analysis
|
Hao, Yanjie |
|
|
67 |
C |
p. |
article |
14 |
Fostering connections at OMERACT 2023: A collaborative approach to Core Outcome Set development
|
Grosskleg, Shawna |
|
|
67 |
C |
p. |
article |
15 |
How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes
|
Goldenberg, Don L |
|
|
67 |
C |
p. |
article |
16 |
Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis
|
Wallwork, Rachel S |
|
|
67 |
C |
p. |
article |
17 |
Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: A population-based study
|
Shi, Lin-Hong |
|
|
67 |
C |
p. |
article |
18 |
Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review
|
Yu, Kunze |
|
|
67 |
C |
p. |
article |
19 |
Large-vessel involvement in ANCA-associated vasculitis: A multicenter case-control study
|
Monghal, V. |
|
|
67 |
C |
p. |
article |
20 |
Letter to the editor regarding “Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial”
|
Chen, Yi |
|
|
67 |
C |
p. |
article |
21 |
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial
|
Ferrero, Stephanie |
|
|
67 |
C |
p. |
article |
22 |
Patient research partner engagement in OMERACT: Enhancing engagement through the implementation of patient engagement in research tools
|
Hofstetter, Catherine |
|
|
67 |
C |
p. |
article |
23 |
Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus
|
Choi, May Y. |
|
|
67 |
C |
p. |
article |
24 |
Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
|
Boukhlal, Sara |
|
|
67 |
C |
p. |
article |
25 |
Reply on « Commentary on giant cell arteritis associated with scalp, tongue or lip necrosis in a French study”
|
Chehem Daoud Chehem, Ferida |
|
|
67 |
C |
p. |
article |
26 |
Response to: Comment to “Vitamin D in psoriatic arthritis—A systematic review and meta-analysis”
|
Radić, Mislav |
|
|
67 |
C |
p. |
article |
27 |
Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis
|
Li, Changhong |
|
|
67 |
C |
p. |
article |
28 |
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know
|
Tonutti, Antonio |
|
|
67 |
C |
p. |
article |
29 |
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group
|
Saygin, Didem |
|
|
67 |
C |
p. |
article |
30 |
The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapy
|
Han, Lin |
|
|
67 |
C |
p. |
article |